Statistics for Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles
Total visits
| views | |
|---|---|
| Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles | 145 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| Angiotensin II receptor type 1 blockade decreases CTGFCCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles.pdf | 49 |
| Angiotensin II receptor type 1 blockade decreases CTGFCCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles.pdf(legacy) | 8 |
Top country views
| views | |
|---|---|
| United States | 44 |
| Chile | 34 |
| Germany | 30 |
| Russia | 2 |
| Sweden | 2 |
| AP | 1 |
| Brazil | 1 |
| China | 1 |
| Ireland | 1 |
| Mexico | 1 |
| Vietnam | 1 |
Top city views
| views | |
|---|---|
| Miami | 37 |
| Santiago | 27 |
| Concepcion | 5 |
| Alameda | 4 |
| Balingen | 4 |
| Kempen | 2 |
| Åkersberga | 2 |
| Campbell | 1 |
| Dublin | 1 |
| Hanoi | 1 |
| Hebei | 1 |
| Jacksonville | 1 |
| Jundiai | 1 |
| Sacramento | 1 |
| Vilsbiburg | 1 |
| Zapopan | 1 |